These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14722707)

  • 81. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 83. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
    Roberts CA; Quednow BB; Montgomery C; Parrott AC
    Neurosci Biobehav Rev; 2018 Jan; 84():470-482. PubMed ID: 28801175
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes.
    Davis M
    Neurosci Biobehav Rev; 1980; 4(2):241-63. PubMed ID: 6106916
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neuroplasticity in the acoustic startle reflex in larval zebrafish.
    López-Schier H
    Curr Opin Neurobiol; 2019 Feb; 54():134-139. PubMed ID: 30359930
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Research Progress in the Study of Startle Reflex to Disease States.
    Zhang J; Wang M; Wei B; Shi J; Yu T
    Neuropsychiatr Dis Treat; 2022; 18():427-435. PubMed ID: 35237036
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Hyperexplexia].
    Chevrel J; Berthier M; Bonneau D; Cardona J; Oriot D
    Arch Pediatr; 1995 May; 2(5):469-72. PubMed ID: 7640741
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.
    Heekeren K; Daumann J; Geyer MA; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2004 May; 173(3-4):418-24. PubMed ID: 14722707
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
    Guillot C
    J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.